Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

Headlines,New Institutional Investments in Thermo Fisher Scientific,Institutional Ownership Remains Strong in ...

Point-of-Care Food Sensitivity Testing Market. The global point-of-care food sensitivity testing market has reached a ...

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to ...

With a sales record of $3.5 billion and employing more than 9,500 people, Life Technologies (formerly Invitrogen) acquired Quantum Dot Corporation, the company that pioneered the commercialization ...

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Liquid Biopsy Market The demand for non-invasive diagnostic techniques is a major driver for the Global Liquid Biopsy <a target=_blank hr ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $559.65 which represents a decrease of $-2.06 or -0.37% from the prior close of $561.71. The stock opened at $562.46 and ...